Cross-AAPs acceleration of genomics for escalating infectious diseases

Year of award: 2024

Grantholders

  • Le Van Tan

    Oxford Clinical Research Unit - Vietnam, Vietnam

  • Dr Anuraj Shankar

    University of Oxford, United Kingdom

  • Dr Muki Shey

    University of Cape Town, South Africa

  • Prof Lynette Isabella Oyier

    Kemri-Wellcome Trust Research Programme, Kenya

  • Prof Lynette Isabella Oyier

    Kemri-Wellcome Trust Research Programme, Kenya

  • Anne Amulele

    Kemri-Wellcome Trust Research Programme, Kenya

  • Dr Elizabeth Batty

    University of Oxford, United Kingdom

  • Dr Duy Pham

    Oxford Clinical Research Unit - Vietnam, Vietnam

  • Dr Narisara Chantratita

    Mahidol University, Thailand

  • Dr Juthathip Mongkolsapaya

    University of Oxford, United Kingdom

  • Dr Raph Hamers

    University of Oxford, United Kingdom

  • Dr Jennifer Cornick

    University of Liverpool, United Kingdom

  • Prof Marvin HSIAO

    National Health Laboratory Service, South Africa

  • Dr Alexander Sigal

    Africa Health Research Institute, South Africa

  • Dr Audrey Dubot-Pérès

    Institut de Recherche pour le Developpement, France

Project summary

Throughout the COVID-19 pandemic, the Africa Asia Programmes (AAPs), AHRI, KWTRP, MLW, MORU and OUCRU, and CIDRI-Africa (Discovery Platform), played a crucial role supporting Ministries of Health with diagnostics, genomic surveillance and real-time data to guide decision-making. We propose to now apply these established capacities to pathogens with an escalating infection burden in Africa and Southeast Asia, driven by climate change or the emergence of drug resistance, and for which there is a dearth of genomics data across Africa and Southeast Asia limiting effective action. The selected pathogens are: 1) the vector-borne dengue and chikungunya viruses; 2) multidrug-resistant Klebsiella pneumoniae; and 3) Mycobacterium tuberculosis. The proposed project will harmonise resources for archived and prospective sample collection and surveillance, whole-genome and targeted next-generation sequencing, metagenomics, bioinformatics, and the interoperability of genomic data and metadata across sites via the HL7 Fast Healthcare Interoperability Resources data standard. We aim to determine the national and international spread of these infections to inform national policy strategies for arboviruses control and antibiotic stewardship. The project will be managed via shared governance and oversight, enabling active engagement of the multidisciplinary teams with policy stakeholders across eight countries to accelerate translation of our findings to practice.